Pfizer Setback Disappointing, Not Catastrophic
By Chad Brand of Peridot Capitalist I was actually planning a broader pharmaceutical post , but in light of the Pfizer (PFE) news over the weekend, I just wanted to talk about them a…
By Chad Brand of Peridot Capitalist I was actually planning a broader pharmaceutical post , but in light of the Pfizer (PFE) news over the weekend, I just wanted to talk about them a…
From BioHealth Investor Shares of Onyx Pharmaceuticals (ONXX) dropped more than 30% on Monday after the company announced at a teleconference that its phase III clinical trial evaluating its cancer drug Nexavar failed to…
Pfizer (PFE) had its CEO interviwed by Mike Huckman on CNBC today. Mike Huckman even asked him how a "guy that used to sell chicken for Boston Market that is fairly new to the…
This morning Cramer on TheStreet.com posted his comments regarding Pfizer’s (PFE) drug blow-up this weekend. You’ll need to go visit thestreet.com there about what he said exactly, but keep in mind he has been…
Those who read this column regularly know our doubts about Prizer’s new blockbuster drugs. These are the ones the are to replace all of those going off patent and into the hands of the…
Pfizer (PFE) met with analysts yesterday and said it was on the road to introducing some blockbuster drugs. Wall St. should hope so. With a sales force reduction of 2,000, generics snapping at its…